Agenda – 2021

23rd Annual MAD-ID Meeting
May 19-22, 2021

NOTE:  “AASP” denotes an Advanced Antimicrobial Stewardship Program session (entire program constitutes 16 hours CPE [1.6 CEU] and 16 hours CME (AMA PRA Category 1 Credit(s)™)

Thursday, May 20, 2021
12:15 pm - 1:45 pmIndependent Satellite Symposium (optional; not part of official program):
Conceptualization of Treating Infectious Diseases: A Framework to Achieve Optimal Outcomes
2:00 pm - 2:15 pmWelcome and Opening Remarks
2:15 pm - 4:15 pmClassrooms #1-4 (attend two of the four offered)
Stewardship Classroom #1: (1 hour, repeated)
Antimicrobial Stewardship in Challenging Environments (AASP); Eddie A. Stenehjem, MD, MSc;
Activity Type: Application
ACPE Program: 0485-0000-021-001-L04-P (1.0 Contact Hour)
Learning Objectives:
1. Outline challenges to implementing antimicrobial stewardship in various healthcare settings (e.g. rural, small hospital, telehealth)
2. Identify creative approaches to improving access to antimicrobial stewardship expertise
3. Give an example of how a healthcare network can be used to facilitate antibiotic stewardship in a challenging setting
Stewardship Classroom #2: (1 hour, repeated)
How to Interpret and Apply Data from in vitro Studies to Patient Care (AASP); Katie E. Barber, PharmD;
Activity Type: Application
ACPE Program: 0485-0000-021-002-L01-P (1.0 Contact Hour)
Learning Objectives:
1. Describe the types of in vitro susceptibility and pharmacodynamic data that are available in the literature
2. List the pros and cons for using these data for clinical translation
3. Given a clinical situation, use these data to determine/design specific antibiotic therapy
Stewardship Classroom #3: (1 hour, repeated)
How to Win Friends and Influence Outpatient Antibiotic Use (AASP); Lisa E. Dumkow, PharmD;
Activity Type: Application
ACPE Program: 0485-0000-021-003-L04-P (1.0 Contact Hour)
Learning Objectives:
1. State two or more rationales for expansion of an antimicrobial stewardship program into the outpatient arena
2. List two or more parties delivering care in the outpatient environment who would be natural partners for stewardship efforts
3. Propose and defend at least two stewardship initiatives that are likely to affect appropriateness of antimicrobial use and/or safety in the outpatient environment
Stewardship Classroom #4: (1 hour, repeated)
Tales from the Trenches: Difficult Stewardship Challenges from our Community; Kate E. DeSear, PharmD, Lynne C. Krop, PharmD, and David L. Lourwood, PharmD;
Activity Type: Application
ACPE Program: 0485-0000-021-004-L04-P (1.0 Contact Hour)
Learning Objectives:
1. Identify strategies to take advantage of financial incentives (e.g. new technology add-on payments) in the use of novel antimicrobials
2. Outline a systematic approach for recommending optimal therapy in patients with C. difficile infection
3. Explain to fellow practitioners how provider-level antibiotic use data can be used to improve
de-escalation of broad spectrum antibiotics
4:15 pm - 5:45 pmA New Era in HIV Management (AASP); ACPE Program: 0485-0000-021-005-L02-P (1.5 Contact Hours); ACPE Activity Type: Application
Topic 1: New Therapies, New Problems; Roger Bedimo, MD
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. Describe recent trends in the epidemiology of HIV
2. Explain the strengths and limitations of new treatments for HIV to patients and other healthcare practitioners
3. Identify factors that can complicate choice of antiretroviral therapy for patients with HIV
Topic 2: Real Life Challenges in HIV Therapy; Melissa Badowski, PharmD, MPH
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. Evaluate the impact of generic antiretrovirals on management of HIV in the United States
2. Outline approaches for improving access to care for patients with HIV or at high risk
3. Given a patient case, identify safety considerations important in the selection and monitoring of antiretroviral therapy
5:45 pm - 6:00 pmClosing Remarks
Friday, May 21, 2021
8:45 am - 10:15 amIndependent Satellite Symposium
10:30 am – 10:45 amWelcome and Opening Remarks (repeated)
10:45 am - 12:15 pmCOVID 19 (AASP)
ACPE Program: 0485-0000-021-006-L01-P (1.5 Contact Hours); ACPE Activity Type: Application
Topic 1: Public Health and Clinical Challenges; Roger Bedimo, MD
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. Explain the evolving incidence and epidemiology of COVID-19
2. Compare the manifestations of mild, moderate and severe COVID-19 disease
3. Analyze and describe the current data regarding post-COVID sequelae
Topic 2: Treatment Challenges, Access and Impact of AMS Since
COVID 19 Outbreak; Julie Ann Justo, PharmD, MS
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. Recommend guidelines and protocols to improve treatment for COVID-19
2. Describe two or more ways that AMS has changed since the COVID pandemic began
3. Describe how the access and pharmacy restrictions to COVID-related treatment affects patient care
12:15 pm - 1:45 pmA Public Health Crisis (AASP)
ACPE Program: 0485-0000-021-007-L01-P (1.5 Contact Hours)
ACPE Activity Type: Knowledge
Topic 1: A Public Health Crisis: Advances in Vaccines; Jeffrey A. Goad, PharmD, MPH
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. List newer vaccines and explain the importance/clinical relevance of their introduction
2. List recently updated/improved vaccine products and explain the importance/clinical relevance of those changes
3. Describe recent changes in ACIP guidelines and adhere to those changes in clinical practice

Topic 2: A Public Health Crisis: Vaccine Mythbusters; Marc Hutchison, PhD
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. List two or more common myths regarding standard immunizations (as recommended by ACIP)
2. Describe the sources of information anti-vaxers cite to justify their beliefs
3. Propose two or more arguments that might be effective in convincing doubtful patients to accept standard vaccinations
1:45 pm – 2:00 pmBreak
2:00 pm - 3:00 pmIndependent Satellite Symposium (optional; not part of official program);
The Power of the Microbiome - Can it be unlocked to break the cycle of recurrent Clostridioides difficile infection?
3:00 pm - 4:30 pmCombination Therapy for Serious Infections (AASP);
ACPE Program: 0485-0000-021-008-L01-P (1.5 Contact Hours)
ACPE Activity Type: Application
Topic 1: Combination Therapy for Serious Infections: Staphylococcus aureus; George Sakoulas, MD
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. Identify patients at risk that may benefit from combination therapy
2. Apply the knowledge gained from this lecture to select appropriate therapy
3. Evaluate a patient's response to therapy based on signs, symptoms and laboratory assessment
Topic 2: Combination Therapy for Serious Infections: Gram-Negative Infections; Ryan K. Shields, PharmD, MS
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. Explain the challenges associated with the treatment of gram-negative pathogens to clinical practitioners
2. Describe the in vitro and animal data that support combination therapy for gram-negative pathogens
3. Discuss the controversies and potential studies needed to support the use of combination therapy
4:30 pm - 6:00 pmUpdate on Vancomycin (AASP)
ACPE Program: 0485-0000-021-009-L01-P (1.5 Contact Hours)
ACPE Activity Type: Knowledge
Topic 1: Demystifying Two-sample and Bayesian Estimated AUC: Simple but no Simpler; Manjunath (Amit) P. Pai, PharmD, FCP
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. Review the translational relationship between different measurements of exposure
2. Compare AUC estimates for a given clinical scenario based on 1-sample and 2-sample measurements
3. Contrast the advantages and disadvantages of Bayesian and 2-sample methods for vancomycin dosing and monitoring
Topic 2: Implementing the 2020 Vancomycin Dosing and Monitoring Guidelines:
Finding a Path Forward; Emily Heil, PharmD, MS
Learning Objectives
Upon completion of this session, the participant will be able to:
1. Provide an overview of the key components for implementing the 2020 vancomycin guidelines at your institution
2. Identify potential barriers for implementing vancomycin AUC dosing and monitoring
3. Describe the specific educational and mechanistic methodologies for successfully implementing vancomycin AUC dosing and monitoring
6:00 pm - 6:15 pmBreak
6:15 pm - 7:45 pmAntimicrobial Stewardship in Special Populations (AASP)
ACPE Program: 0485-0000-021-010-L01-P (1.5 Contact Hours)
ACPE Activity Type: Knowledge
Topic 1: Pediatrics; Tracy N. Zembles, PharmD
Upon completion of this session, the participant will be able to:
1. Explain how the differences in pediatric infectious disease epidemiology or management require differences in stewardship initiatives
2. Design a stewardship initiative for implementation that has proven effective in the pediatric inpatient environment
3. Describe two or more stewardship initiatives that have proven effective in the pediatric outpatient environment
Topic 2: Adults with Cystic Fibrosis; Wendy Bullington, PharmD
Upon completion of this session, the participant will be able to:
1. List one or more opportunities for impactful stewardship initiatives in the cystic fibrosis population
2. Describe the elements of successful stewardship interventions that have a proven effect in adult cystic fibrosis patients
3. Justify use of healthcare personnel for stewardship activities in inpatient and/or outpatient cystic fibrosis care programs
7:45 pm - 8:00 pmClosing Remarks
Saturday, May 22, 2021
8:45 am - 10:15 amIndependent Satellite Symposium
10:30 am - 12:00 pmHot Topics (AASP)
ACPE Program: 0485-0000-021-011-L01-P (1.5 Contact Hours)
ACPE Activity Type: Knowledge
Topic 1: Top 10 Papers from 2020; Ryan K. Shields, PharmD, MS and Erin K. McCreary, PharmD
Upon completion of this session, the participant will be able to:
1. Describe an important study published in 2020 and explain how you may apply its finding to your practice
2. Discuss the major controversies published in the ID literature in 2020
3. List the winners and losers for therapeutic advances from this year in ID pharmacotherapy
12:00 pm - 2:00 pmClassrooms #5-8 (attend two of the four offered)
Stewardship Classroom #5: (1 hour, repeated)
Effective Use of EMR Programming to Implement Antibiotic Guidelines/Pathways (AASP); David R. Ha, PharmD;
ACPE Activity Type: Application
ACPE Program: 0485-0000-021-012-L04-P (1.0 Contact Hour)
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. Discuss best practices of electronic medical record design to improve compliance with clinical guidelines
2. Identify tools within electronic medical records that can be used in implementing or monitoring antimicrobial stewardship strategies
3. Given a clinical problem, design a potential solution utilizing electronic medical record technologies
Stewardship Classroom #6: (1 hour, repeated)
Dose Optimization of Beta-Lactams (AASP); Charles A. Peloquin, PharmD
ACPE Activity Type: Application
ACPE Program: 0485-0000-021-013-L01-P (1.0 Contact Hour)
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. Describe the key pharmacokinetic/pharmacodynamic parameters that optimize beta-lactam antibiotics
2. Compare beta-lactams that are good candidates for dose optimization strategies
3. Articulate examples of successful beta-lactam optimization programs that have improved patient outcomes
Stewardship Classroom #7: (1 hour, repeated)
Supporting ID/ASP Professionals: Preventing Burnout in an Era of Doing More with Less (AASP); Erin K. McCreary, PharmD;
ACPE Activity Type: Application
ACPE Program: 0485-0000-021-014-L04-P (1.0 Contact Hour)
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. Describe the prevalence and consequences of burnout in healthcare professions in the context of infectious diseases workforce
2. Compare the typical causes of burnout in individuals and analyze the systemic contributing factors
3. Demonstrate prevention strategies for mitigating burnout
Stewardship Classroom #8: (1 hour, repeated)
Developing and Using your Antibiogram (AASP)
ACPE Activity Type: Application
ACPE Program: 0485-0000-021-015-L04-P (1.0 Contact Hour)
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. State the basic requirements for assembly and dissemination of an antibiogram as suggested by CLSI
2. Summarize the susceptibility data that should and should not be included in an antibiogram
3. Assemble a combination antibiogram and demonstrate its application/use to clinical decision making
2:00 pm - 2:15 pmBreak
2:15 pm – 3:45 pmEmerging and Difficult to Treat Infections
ACPE Program: 0485-0000-021-016-L01-P (1.5 Contact Hours)
ACPE Activity Type: Application
Topic 1: Candida auris;
Jeffrey M. Rybak, PharmD, PhD
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. Describe the pharmacological and clinical consequences of antifungal resistance in Candida species
2. Identify epidemiological features associated with Candida auris
3. Recommend and justify two or more infection control and treatment strategies suggested for suspected or known Candida auris
Topic 2: Emerging and Difficult to Treat Infections: Nontuberculous Mycobacteria; Wendy Bullington, PharmD
Learning Objectives:
Upon completion of this session, the participant will be able to:
1. Describe the epidemiology of nontuberculous mycobacterial lung disease (NTM-LD)
2. Outline major recommendations in diagnosis and monitoring of NTM-LD
3. Given a clinical scenario, describe how to implement evidence-based treatment recommendations for NTM-LD
3:45 pm - 4:00 pmClosing Remarks